Siga Technologies INC Contract with Customer, Liability, Change in Timeframe, Performance Obligation Satisfied, Revenue Recognized
Siga Technologies INC (SIGA) reported Contract with Customer, Liability, Change in Timeframe, Performance Obligation Satisfied, Revenue Recognized of $1.00 million for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-05.
Discontinued › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized · last filed 2019-11-05
- Siga Technologies INC contract with customer, liability, change in timeframe, performance obligation satisfied, revenue recognized for the quarter ending 2019-03-31 was $400.00K.
- Siga Technologies INC contract with customer, liability, change in timeframe, performance obligation satisfied, revenue recognized for fiscal 2018 was -$376.36M.
| Period end | Contract with Customer, Liability, Change in Timeframe, Performance Obligation Satisfied, Revenue Recognized 3 month | Contract with Customer, Liability, Change in Timeframe, Performance Obligation Satisfied, Revenue Recognized 6 month | Contract with Customer, Liability, Change in Timeframe, Performance Obligation Satisfied, Revenue Recognized 9 month | Contract with Customer, Liability, Change in Timeframe, Performance Obligation Satisfied, Revenue Recognized 12 month |
|---|---|---|---|---|
| 2019-09-30 | $1.00M 10-Q · filed 2019-11-05 | |||
| 2019-06-30 | $1.00M 10-Q · filed 2019-08-06 | |||
| 2019-03-31 | $400.00K 10-Q · filed 2019-05-02 | |||
| 2018-12-31 | -$376.36M 10-K · filed 2019-03-06 | |||
| 2018-09-30 | -$376.43M 10-Q · filed 2018-11-06 | |||
| 2018-06-30 | -$740.28K 10-Q · filed 2018-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |